Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
Bergmann L, Maute L, Heil G, Rüssel J, Weidmann E, Köberle D, Fuxius S, Weigang-Köhler K, Aulitzky WE, Wörmann B, Hartung G, Moritz B, Edler L, Burkholder I, Scheulen ME, Richly H. Bergmann L, et al. Eur J Cancer. 2015 Jan;51(1):27-36. doi: 10.1016/j.ejca.2014.10.010. Epub 2014 Nov 5. Eur J Cancer. 2015. PMID: 25459392 Clinical Trial.
Temsirolimus for advanced renal cell carcinoma.
Bergmann L, Maute L, Guschmann M. Bergmann L, et al. Expert Rev Anticancer Ther. 2014 Jan;14(1):9-21. doi: 10.1586/14737140.2014.864562. Epub 2013 Dec 6. Expert Rev Anticancer Ther. 2014. PMID: 24313573
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society.
Bergmann L, Grünwald V, Maute L, Grimm MO, Weikert S, Schleicher J, Klotz T, Greiner J, Flörcken A, Hartmann A, Gauler T. Bergmann L, et al. Oncol Res Treat. 2020;43(7-8):333-339. doi: 10.1159/000508450. Epub 2020 Jun 15. Oncol Res Treat. 2020. PMID: 32541143 Clinical Trial.
[The immunotherapy of advanced renal cell carcinoma].
Bergmann L, Weidmann E, Mitrou PS. Bergmann L, et al. Dtsch Med Wochenschr. 1991 Mar 8;116(10):384-90. doi: 10.1055/s-2008-1063624. Dtsch Med Wochenschr. 1991. PMID: 1705879 Review. German. No abstract available.
[Systemic therapy of metastatic renal cell carcinoma].
Maute L, Bergmann L. Maute L, et al. Among authors: bergmann l. Dtsch Med Wochenschr. 2016 Apr;141(7):466-9. doi: 10.1055/s-0042-104594. Epub 2016 Mar 31. Dtsch Med Wochenschr. 2016. PMID: 27031198 German.
498 results